The IGF2 (Insulin-like Growth Factor 2), a protein that carries out a fundamental role in numerous physiological functions and in memory and learning processes, could be a promising therapeutic target for the cognitive deterioration associated with ageing and, thus, in diseases such as Alzheimer’s. This is the kernel of the PhD thesis by María Pascual, researcher at the Faculty of Medicine of the University of Navarra, and the main results of which were published in the EMBO Molecular Medicine journal.
|2014/12/17||Mediterranean diet reduces the overweight and obesity linked with menopause|
|2014/12/17||Prevention of virtual harassment|
|2014/12/16||Lead islands in a graphene sea magnetise the material of the future|
|2014/12/16||University of the Basque Country research compares levels of social trust and cooperation in Euskadi and Catalonia|
|2014/12/16||The University of Navarra provides online training with experts in geriatric nutrition|
|2014/12/16||The Spanish Maritime Cluster awards Indar 2014 prize for Innovation and Competitiveness|
|2014/12/15||Latest advances in stainless steel welding. Shielding gases: trends and novelties|
|2014/12/15||NEIKER presents plant to transform organic waste into high-quality fertiliser|
|2014/12/15||PEFC-Euskadi celebrates its tenth year|
The use of the contents of this website is forbidden without permission.
Copyright © 2007 Elhuyar Fundazioa